Multicentre Study of Olaparib Maintenance Monotherapy in Platinum Sensitive Relapsed Non gBRCAm Ovarian Cancer Patients

Clinical trial NCT03402841 · COMPLETED

Trial details

NCT number: NCT03402841
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Non-Germline BRCA Mutated Ovarian Cancer

Start date: 2018-01-30
Primary completion: 2020-10-02
Enrollment: 279

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.